(9H-芴-9-基)甲基N-(2-((4-(4-(3-溴-4-氟苯基)-5-氧代-4,5-二氢-结构式
|
常用名 | (9H-芴-9-基)甲基N-(2-((4-(4-(3-溴-4-氟苯基)-5-氧代-4,5-二氢- | 英文名 | (9H-Fluoren-9-Yl)Methyl N-(2-((4-(4-(3-Bromo-4-Fluorophenyl)-5-Oxo-4,5-Dihydro-1,2,4-Oxadiazol-3-Yl)-1,2,5-Oxadiazol-3-Yl)Amino)Ethyl)Sulfamoylcarbamate |
|---|---|---|---|---|
| CAS号 | 1771804-78-4 | 分子量 | 686.47 | |
| 密度 | 1.78±0.1 g/cm3(Predicted) | 沸点 | N/A | |
| 分子式 | C27H21BrFN7O7S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | (9H-芴-9-基)甲基N-(2-((4-(4-(3-溴-4-氟苯基)-5-氧代-4,5-二氢- |
|---|---|
| 英文名 | Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]amino]sulfonyl]-, 9H-fluoren-9-ylmethyl ester |
| 中文别名 | (9H-芴-9-基)甲基N-(2-((4-(4-(3-溴-4-氟苯基)-5-氧代-4,5-二氢-1,2,4-噁二唑-1-基)吡啶-3-基)-1,2,5-噁二唑-3-基)氨基)乙基)氨磺酰;(9H-芴-9-基)甲基N-(2 - ((4-(4-(3-溴-4-氟苯基)-5-氧代-4,5-二氢-;(9H-芴-9-基)甲基(N-(2-((4-(4-(3-溴-4-氟苯基)-5-氧代-4,5-二氢-1,2,4-噁二唑-3-基)-1,2,5-噁二唑-3-基)氨基)乙基)氨基甲酸酯 |
| 英文别名 | 更多 |
| 密度 | 1.78±0.1 g/cm3(Predicted) |
|---|---|
| 分子式 | C27H21BrFN7O7S |
| 分子量 | 686.47 |
| 精确质量 | 685.039063 |
| LogP | 3.22 |
| 折射率 | 1.754 |
| 储存条件 | 室温 |
| Carbamic acid, N-[[[2-[[4-[4-(3-bromo-4-fluorophenyl)-4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]amino]sulfonyl]-, 9H-fluoren-9-ylmethyl ester |
| MFCD30536401 |
| 9H-Fluoren-9-ylmethyl {[2-({4-[4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl}amino)ethyl]sulfamoyl}carbamate |